A Phase 1 Absorption, Metabolism and Excretion Study of [14C]RDEA3170 Orally Administered to Healthy Adult Male Subjects
Phase of Trial: Phase I
Latest Information Update: 28 Feb 2018
At a glance
- Drugs Verinurad (Primary)
- Indications Gout; Hyperuricaemia
- Focus Pharmacokinetics
- Sponsors Ardea Biosciences
- 28 Feb 2018 Results published in the Drug Metabolism and Disposition Journal.
- 08 Jan 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 03 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.